Capexil - Due diligence report

A 360° intelligence report on Capexil: trust score, financial health, credit view, compliance, directors, growth and distress signals - gene…

1958-03-28 Kolkata, West Bengal Active Unlisted Active Compliant
Share
CA Capexil
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Capexil — 360° Intelligence Report

Generated from MCA filings & public records
81/100
Trust Score
Low Risk

Capexil is assessed as Low Risk with a Trust Score of 81/100. Capexil is an active public not for profit company incorporated in 1958, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Capexil snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
81/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
35/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 86/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • 4 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 35/100
NameDIN / PANDesignationAppointedTenureDIN status
DEEPENDRA SINGH 01234567 Director 01/04/2018 6 yrs Approved
PRADEEP KUMAR KHERUKA 01234567 Director 01/04/2018 6 yrs Approved
GANESAN ASHOKAN 01234567 Director 01/04/2018 6 yrs Approved
CHITTA RANJAN BHATTACHARJEE 01234567 Director 01/04/2018 6 yrs Approved
VAIDYALINGAM 01234567 Director 01/04/2018 6 yrs Approved
RANGASWAMI VEERAMANI 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • RANGASWAMI VEERAMANI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 4 director exits in 3 years - high churn.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 80
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 68+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
4 director exits within 2 years.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment76/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view86/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
26 Dec 2025
Director ceased
SUBBARAJ VENKATESH KUMAR
Director ceased
RAMESH KUMAR MITTAL
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
16 Oct 2024
Director ceased
SATISH MALHOTRA
Director ceased
SHIV KUMAR JAIN
31 May 2023
Director ceased
PHILIP CHACKO MUNDANILKUNNATHIL
20 Dec 2022
Director ceased
BHAVANJI HARIBHAI PATEL
14 Dec 2021
Director ceased
RAVINDER REDDY MADADI
Director ceased
MONIT MALHOTRA
29 Dec 2020
Director appointed
VAIDYALINGAM (Director)
29 Oct 2020
Director ceased
MAZHAR FAROOQ VOHRA
27 Dec 2019
Director ceased
SURINDER PAL SINGH GULATI
Director ceased
PRASANTH PALANISAMY
20 Jun 2019
Director ceased
SANKARALINGAM ANNAMALAI
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); review board churn before relying on management continuity.
4 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Fivebro Water Services Private Limited U24230GJ2021PTC122403 Ahmedabad, Gujarat, India
Classic Associates Teleservices Private Limited U74999PN2020PTC194833 Pune, Maharashtra, India
Qship Maritime Management Private Limited U63032MH2008PTC188719 Mumbai, Maharashtra, India
Hirepro Technologies Private Limited U72200KA2022PTC159969 Bangalore, Karnataka, India
The Cotton Textiles Export Promotion Council U91110MH1954NPL009385 Mumbai, Maharashtra, India
Advance Emergency Systems Private Limited U32107MH2007PTC171531 Mumbai, Maharashtra, India
On Electronics Private Limited U74990KA2009FTC083028 Bangalore South, Karnataka, India
Genuine Copier Venture Private Limited U52602HR2013PTC048337 Gurgaon, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Capexil before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Capexil: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Capexil - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 81/100, distress signals and MSME payment-delay disclosures - know whether Capexil pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Capexil - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Capexil an active company?

Capexil has MCA status “Active” with a compliance score of 86/100 (Low Risk).

Is Capexil financially healthy?

Capexil has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Capexil?

Its overall Trust Score is 81/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Capexil?

See the directors and ownership sections above for board and shareholding detail. 6 active director(s) are on record.

Does Capexil have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Capexil up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).

Is it risky to lend to Capexil?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.